VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $984,000 | -25.0% | 42,350 | -48.6% | 0.46% | -25.4% |
| Q1 2018 | $1,312,000 | +465.5% | 82,416 | +6239.7% | 0.62% | +558.5% |
| Q3 2015 | $232,000 | -19.7% | 1,300 | 0.0% | 0.09% | +1.1% |
| Q2 2015 | $289,000 | -36.8% | 1,300 | -43.5% | 0.09% | -16.2% |
| Q1 2015 | $457,000 | +62.1% | 2,300 | -4.2% | 0.11% | +362.5% |
| Q4 2013 | $282,000 | -50.0% | 2,400 | -55.6% | 0.02% | -44.2% |
| Q3 2013 | $564,000 | +21.0% | 5,410 | 0.0% | 0.04% | +10.3% |
| Q2 2013 | $466,000 | -87.0% | 5,410 | -88.7% | 0.04% | -84.5% |
| Q1 2013 | $3,577,000 | +264.3% | 47,680 | +152.3% | 0.25% | +445.7% |
| Q2 2011 | $982,000 | – | 18,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |